Across TCGA pan-cancer cohorts, FCGR1CP RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FCGR1CP data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FCGR1CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FCGR1CP expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.
KIRC, SKCM, and UVM are the cancer types where FCGR1CP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.